Konstantinos Krasagakis
Konstantinos Krasagakis
Professor of Dermatology, School of Medicine, University of Crete
Email verificata su
Citata da
Citata da
Expression of interleukin 10 in human melanoma
S Krüger-Krasagakes, K Krasagakis, C Garbe, E Schmitt, C Hüls, ...
British journal of cancer 70 (6), 1182-1185, 1994
Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanoma
K Krasagakis, D Thölke, B Farthmann, J Eberle, U Mansmann, ...
British journal of cancer 77 (9), 1492-1494, 1998
Translation initiation factor eIF‐4A1 mRNA is consistently overexpressed in human melanoma cells in vitro
J Eberle, K Krasagakis, CE Orfanos
International journal of cancer 71 (3), 396-401, 1997
Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines
DJ Morré, E Sun, C Geilen, LY Wu, R De Cabo, K Krasagakis, CE Orfanos, ...
European Journal of Cancer 32 (11), 1995-2003, 1996
Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo
MB ABDEL‐NASER, S Krüger‐Krasagakes, K Krasagakis, H Gollnick, ...
Pigment Cell Research 7 (1), 1-8, 1994
RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients
B Farthmann, J Eberle, K Krasagakis, M Gstöttner, N Wang, S Bisson, ...
Journal of investigative dermatology 110 (3), 263-267, 1998
Growth control of melanoma cells and melanocytes by cytokines
K Krasagakis, C Garbe, CC Zouboulis, CE Orfanos
Skin cancer: Basic science, clinical research and treatment, 169-182, 1995
Effects of interferons and cytokines on melanoma cells
C Garbe, K Krasagakis
Journal of investigative dermatology 100 (2), S239-S244, 1993
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype
C Garbe, K Krasagakis, CC Zouboulis, K Schröder, S Krüger, R Stadler, ...
Journal of investigative dermatology 95 (6), S231-S237, 1990
Management of severe scleroderma with long-term extracorporeal photopheresis
K Krasagakis, E Dippel, J Ramaker, M Owsianowski, CE Orfanos
Dermatology 196 (3), 309-315, 1998
Primary care and pattern of skin diseases in a Mediterranean island
EK Symvoulakis, K Krasagakis, ID Komninos, I Kastrinakis, I Lyronis, ...
BMC Family Practice 7, 1-6, 2006
Cutaneous mastocytosis in adults: evaluation of 14 patients with respect to systemic disease manifestations
B Tebbe, PG Stavropoulos, K Krasagakis, CE Orfanos
Dermatology 197 (2), 101-108, 1998
Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance
K Krasagakis, G Samonis, P Maniatakis, S Georgala, A Tosca
Dermatology 212 (1), 31-35, 2005
Analysis of epidemiology, clinical features and management of erysipelas
K Krasagakis, A Valachis, P Maniatakis, S Krüger‐Krasagakis, G Samonis, ...
International journal of dermatology 49 (9), 1012-1017, 2010
Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or-gamma inhibit proliferation and all interferons significantly modulate the cell …
K Krasagakis, C Garbe, S Kruger, CE Orfanos
Journal of investigative dermatology 97 (2), 364-372, 1991
Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic …
D Nikitovic, M Assouti, M Sifaki, P Katonis, K Krasagakis, NK Karamanos, ...
The international journal of biochemistry & cell biology 40 (1), 72-83, 2008
Overview of Merkel cell carcinoma and recent advances in research.
K Krasagakis, AD Tosca
International Journal of Dermatology 42 (9), 2003
Merkel cell carcinoma: report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivity
K Krasagakis, B Almond-Roesler, CC Zouboulis, B Tebbe, E Wartenberg, ...
Journal of the American Academy of Dermatology 36 (5), 727-732, 1997
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
K Krasagakis, C Garbe, PI Schrier, CE Orfanos
Anticancer research 14 (6B), 2565-2571, 1994
Differentiation between Merkel cell carcinoma and malignant melanoma: an immunohistochemical study
GJ Kontochristopoulos, PG Stavropoulos, K Krasagakis, S Goerdt, ...
Dermatology 201 (2), 123-126, 2000
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20